Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trisomy 2 and 20 in two hepatoblastomas.

S W Soukup1, B L Lampkin

  • 1Division of Human Genetics, Children's Hospital Medical Center Research Foundation, Cincinnati, Ohio 45229-2899.

Genes, Chromosomes & Cancer
|May 1, 1991
PubMed
Summary

Cytogenetic analysis of pediatric hepatoblastomas reveals evolving chromosomal abnormalities, including trisomy 2 and 20, in primary tumors and metastases. These changes, particularly partial trisomy 2q and 1q, offer insights into tumor progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Succinic dehydrogenase in rat ovarian tissues during pregnancy and lactation.

Endocrinology·2010
Same author

Cytogenetic and molecular studies of Down syndrome individuals with leukemia.

American journal of human genetics·1995
Same author

Triple trisomy in a spontaneous abortion.

Human genetics·1992
Same author

A familial MCA/MR syndrome due to translocation t(10;16) (q26;p13.1): report of six cases.

American journal of medical genetics·1991
Same author

Another synovial sarcoma with t(X;18)

Cancer genetics and cytogenetics·1987
Same author

Continuous human glioma-derived cell lines UC-11MG and UC-302MG. Morphologic, immunocytochemical and chromosomal characterization.

Journal of neuro-oncology·1986

Area of Science:

  • Pediatric oncology
  • Cancer cytogenetics
  • Tumorigenesis

Background:

  • Hepatoblastoma is a rare pediatric liver cancer.
  • Understanding its cytogenetic landscape is crucial for diagnosis and treatment.
  • Comparative genomic hybridization (CGH) and cytogenetic analysis are key tools.

Observation:

  • Two pediatric hepatoblastoma cases were analyzed.
  • Samples included primary tumors, xenografts, and lung metastases.
  • Chromosomal abnormalities were tracked across different stages and models.

Findings:

  • Primary tumors exhibited trisomy 2 and 20, with other structural aberrations.
  • Later stages (xenografts/metastases) showed structural changes in chromosome 2, leading to partial trisomy 2q.

Related Experiment Videos

  • Partial trisomy 1q was consistently observed in advanced stages.
  • Comparison with embryonal rhabdomyosarcoma highlights shared trisomy 2.

    • Implications:

    • Cytogenetic alterations in hepatoblastoma evolve during tumor progression.
    • Partial trisomy 2q and 1q may be significant in advanced disease.
    • Comparative analysis aids in understanding shared mechanisms in pediatric sarcomas and carcinomas.